Abstract:Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor that is both a drug of abuse and an FDA-approved anesthetic used off-label for treatment-resistant depression. Despite its growing clinical use for depression and pain, the relationships between the acute dissociative and affective effects of ketamine that contribute to its abuse liability and therapeutic potential, along with the neural mechanisms underlying these effects, are not well established. To address this need, we have implemented a randomized, double-blinded, placebo-controlled, within-subjects mechanistic trial. Healthy adult subjects undergo infusion with two fixed doses of subanesthetic racemic intravenous (IV) ketamine and placebo and their acute responses are assessed with self-report questionnaires, behavioral measures, hormone levels, and neuroimaging. As planned in our analysis strategy, we present interim results for the first 7 subjects of our study, focusing on dissociative and affective states and resting functional brain coupling signatures of these states. The first key finding was that ketamine induced dose-dependent increases in dissociation and related intoxication. Ketamine also altered affective states, reducing emotional insensitivity but increasing stress assessed by cortisol. Second, ketamine had an effect on altering brain connectivity, particularly for specific connections between regions of the reward and negative affect circuits and involving thalamic sub-regions. Third, regarding brain-response associations, ketamine-induced increases in amygdala-anteroventral thalamus coupling were correlated with greater dissociation and intoxication, whereas decreases in the coupling of the anteromedial thalamus and posterior parietal thalamus were correlated with increased sensory aspects of reward responsiveness. Additional specific correlations were observed between affective measures relevant to reward responsiveness or its absence and drug-altered changes in localized functional connections involving the nucleus accumbens (NAcc), amygdala, and thalamic sub-regions. We also discovered a consistent profile of negative associations between ketamine altered connectivity involving the NAcc and specific thalamic sub-regions and effects of anxiety. Further, drug-altered increases in the coupling of the amygdala and anteroventral thalamus were associated with increases in cortisol, an indicator of biochemical stress. The findings highlight the utility of integrating self-reports, objective measures, and functional neuroimaging to disentangle the brain states underlying specific acute responses induced by ketamine. With the likely continued expansion of FDA indications for ketamine, understanding acute responses and underlying neural mechanisms is important for maximizing the therapeutic potential of ketamine while minimizing the risk of promoting misuse or abuse of this substance. ### Competing Interest Statement The authors have declared no competing interest.

P226. Deconstructing Ketamine-Induced Changes in Cortisol and Dissociative and Affective States in a Controlled Mechanistic Study

Ketamine's acute effects on negative brain states are mediated through distinct altered states of consciousness in humans

Cortical Functional Hyperconnectivity in a Mouse Model of Depression and Selective Network Effects of Ketamine

Ketamine’s Acute Effects on Negative Brain States Are Mediated Through Distinct Altered States of Consciousness in Humans

539. Ketamine’s Acute Effects on Negative Brain States Are Mediated Through Distinct Altered States in Humans

P341. Acute Ketamine Modulates Cognitive Control Network Activity During Cognitive Inhibition: Evidence from a Mechanistic Trial

Acute Ketamine Modulated Functional Brain Coupling and Dissociative and Affective States in Human Subjects: Interim Analyses

Alterations in Regional Homogeneity of Resting-State Brain Activity in Ketamine Addicts

Widespread Cortical Thickness Reductions Following Non-medical Use of Ketamine: a Structural MRI Study of Individuals with Ketamine Dependence

Chronic Administration of Ketamine Mimics the Perturbed Sense of Body Ownership Associated with Schizophrenia

A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adults

Widespread Reductions in Cortical Thickness Following Ketamine Abuse

A Meta-Analysis of fMRI Activation Studies of Ketamine in Healthy Participants

Higher Glutamatergic Activity in the Medial Prefrontal Cortex in Chronic Ketamine Users

Ketamine Exerts Its Sustained Antidepressant Effects Via Cell-Type-specific Regulation of Kcnq2.

Frontal White Matter Abnormalities Following Chronic Ketamine Use: a Diffusion Tensor Imaging Study.

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration

464. Ketamine Disrupts Consciousness in Healthy Controls in Relation With Psychotic-Like Symptoms

Ketamine Contributes to the Alteration of Ca2+ Transient Evoked by Behavioral Tests in the Prelimbic Area of Mpfc: A Study on Chronic CORT-induced Depressive Mice

Cortical thickness of the posterior cingulate cortex is associated with the ketamine-induced altered sense of self: An ultra-high field MRI study

Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression